Pre-clinical validation complete
Numerical simulations and lab-based pre-clinical tests confirm detection of tumours as small as 3 mm in radius, even deep in tissue. Peer-reviewed publication in progress.
POSICS gives surgeons real-time visual guidance during cancer surgery so they can see tumoral tissue, guide removal precisely, and confirm completeness before closing.

Across high-stakes professions, technology has repeatedly transformed decisions by turning what professionals had to interpret into information they can see directly. POSICS brings this same shift to the operating room.
Surgeons rely on pre-operative scans and acoustic camera feedback to estimate tumour position. At the moment of cutting and when checking completeness, there is no direct visual information. Every decision is an inference.
The POSICS camera is placed externally on the patient's body. The surgeon puts on AR glasses and sees a real-time overlay of tumoral tissue, directly mapped onto the surgical field. No inference. No guessing. Direct visualisation.

The external camera detects the radio-tracer signal and provides an immediate visual map of the tumour, directly visible through AR glasses, without interrupting the surgical act.

After excision, the surgeon can hold the camera over the surgical site to confirm no tumoral tissue remains. A critical check that previously depended on post-operative pathology.

POSICS complements existing pre-operative imaging. It doesn't replace the MRI or the CT scan, it brings that information into the surgical act, at the moment critical decisions are made.
Whether you are a surgeon, a hospital, or an investor, we want to hear from you.
POSICS provides direct visual information at the moment when critical decisions are made: during surgery itself. This page explains the system, the surgical workflow, and the validation milestones.
POSICS does not replace pre-operative imaging. It brings that information visually into the operating room, where it matters most.
Standard MRI, CT or PET imaging identifies tumour location. No change to existing protocols.
A tumour-specific radio-pharmaceutical tracer is administered before the operation, a standard practice in radio-guided surgery.
The camera is placed externally on the body. The surgeon wears AR glasses and sees a live overlay of tumoral tissue, showing exactly where to cut and when to stop.
After excision, the camera can be used to verify the surgical site. A real-time completeness check, before wound closure.
It listens for the tracer's signal from outside the body and reconstructs, in real time, a visual map of the tumour. Nothing touches the surgical field.
The image is laid directly over the patient, in the surgeon's own line of sight. No screen to glance at. No looking away.
Fine enough to read a tumour's shape, its margins, the tissue around it. Lesions as small as 3 mm appear, even deep in tissue.
Near real-time. The surgeon moves the camera and the image follows, without breaking the rhythm of the operation.
Sub-millimetre resolution over a 3 × 3 cm active area, with only four readout channels. Compact. Light. Scalable.
The same instrument serves the pre-operative outpatient and the operating room — one tool, many moments in the patient's path.
POSICS doesn't change how surgeons operate.
It changes what they can see while they do.
POSICS is not a concept. It is a working prototype backed by peer-reviewed results, competitive grants, and institutional partnerships.
Numerical simulations and lab-based pre-clinical tests confirm detection of tumours as small as 3 mm in radius, even deep in tissue. Peer-reviewed publication in progress.
Over CHF 600,000 in competitive grants (ATTRACT Phase 1 & 2, HEPIA). Recognition from FONGIT and Swiss Startups. HUG Prize recipient.
Physics, detector engineering, medical imaging, AR software development, and clinical surgery. All the disciplines needed to bring POSICS from prototype to clinical use are represented.
The prototype is ready. Clinical validation on human tissue is the final step before full TRL 6 readiness and hospital deployment.
POSICS was born from a simple observation: surgeons operating on cancer patients are expected to achieve perfect precision, but at the critical moment of the operation, they have no direct visual information about tumour location or completeness of removal.
The project was initiated in the research group of Prof. Domenico della Volpe, through the ATTRACT Phase 1 programme. It has since grown into a full-scale prototype, supported by competitive funding and a multidisciplinary Geneva-based team.
Every year, surgeons close wounds not knowing with certainty whether they removed everything. We are building the tool that changes that.
